BRCA1/BARD1 inhibition of mRNA 3′ processing involves targeted degradation of RNA polymerase II

Frida E. Kleiman, Foon Wu-Baer, Danae Fonseca, Syuzo Kaneko, Richard Baer, James L. Manley

Research output: Contribution to journalArticlepeer-review

123 Scopus citations


Mammalian cells exhibit a complex response to DNA damage. The tumor suppressor BRCA1 and associated protein BARD1 are thought to play an important role in this response, and our previous work demonstrated that this includes transient inhibition of the pre-mRNA 3′ processing machinery. Here we provide evidence that this inhibition involves proteasomal degradation of a component necessary for processing, RNA polymerase II (RNAP II). We further show that RNAP IIO, the elongating form of the enzyme, is a specific in vitro target of the BRCA1/BARD1 ubiquitin ligase activity. Significantly, siRNA-mediated knockdown of BRCA1 and BARD1 resulted in stabilization of RNAP II after DNA damage. In addition, inhibition of 3′ cleavage induced by DNA damage was reverted in extracts of BRCA1-, BARD1-, or BRCA1/BARD1-depleted cells. We also describe corresponding changes in the nuclear localization and/or accumulation of these factors following DNA damage. Our results support a model in which a BRCA1/BARD1-containing complex functions to initiate degradation of stalled RNAP IIO, inhibiting the coupled transcription-RNA processing machinery and facilitating repair.

Original languageEnglish
Pages (from-to)1227-1237
Number of pages11
JournalGenes and Development
Issue number10
StatePublished - 15 May 2005
Externally publishedYes


  • BARD1
  • BRCA1
  • Polyadenylation
  • RNA polymerase II


Dive into the research topics of 'BRCA1/BARD1 inhibition of mRNA 3′ processing involves targeted degradation of RNA polymerase II'. Together they form a unique fingerprint.

Cite this